Published
At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Pooja Ghatalia, MD, of Fox Chase Cancer Center, and Amanda Nizam, MD, of Cleveland Clinic, break down in detail the RETAIN-2 study, a phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
06:15
How Neoadjuvant Therapy Beats Postoperative Chemotherapy
-
05:39
No Chemo? How Immunotherapy Is Shifting the Lung Cancer Landscape
-
08:22
Bladder-Sparing with Systemic Therapy: Insights from RETAIN-2 and Future Directions
-
06:21
RATIONALE-315: Neoadjuvant Tislelizumab + Chemo in Resectable NSCLC – ESMO 2024 Results
-
13:52
Lung Cancer Treatment: Targeted Therapy vs Immunotherapy — What’s Really Working?
-
10:00
SURE-02: Neoadjuvant SG/Pembro, Response-Adapted Bladder Sparing, and Adjuvant Pembro for MIBC
-
19:05
Chemo? Combination Therapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
-
09:28
Advancing Neoadjuvant Therapies: Oncolytic Immunotherapy and Nivolumab in MIBC
-
07:48
Chemo cycles क्यों होते हैं? | Why Chemo is Given in Cycles & Not Continuously! | Dr Praveen Kammar
-
09:35
Expert Cancer Panel: Stage II EGFR mutant NSCLC s/p neoadjuvant chemo/RT/surgery with new RUL nodule
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
